Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women | Zendy

Henry G. Bone | Zendy; David Hosking | Zendy; JeanPierre Devogelaer | Zendy; Joseph Tucci | Zendy; Ronald Emkey | Zendy; Richard P. Tonino | Zendy; Jose Adolfo Rodriguez-Portales | Zendy; Robert W. Downs | Zendy; Jayanti Gupta | Zendy; Arthur C. Santora | Zendy; Uri Liberman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

Author(s) -

Henry G. Bone,

David Hosking,

JeanPierre Devogelaer,

Joseph Tucci,

Ronald Emkey,

Richard P. Tonino,

Jose Adolfo Rodriguez-Portales,

Robert W. Downs,

Jayanti Gupta,

Arthur C. Santora,

Uri Liberman

Publication year - 2004

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa030897

Subject(s) - medicine , osteoporosis , postmenopausal women , alendronic acid , postmenopausal osteoporosis , bone density conservation agents , dentistry , physical therapy , bone density , bisphosphonate , bone mineral

Antiresorptive agents are widely used to treat osteoporosis. We report the results of a multinational randomized, double-blind study, in which postmenopausal women with osteoporosis were treated with alendronate for up to 10 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research